Earth Science Tech (ETST) Cash & Current Investments (2013 - 2026)
Earth Science Tech's (ETST) quarterly Cash & Current Investments came in at $2.2 million in Q1 2026, up 1.8% YoY from $2.1 million in Q1 2025, and up 355.67% on a QoQ basis from $473330.0 in Q4 2025.
Earth Science Tech (ETST) Cash & Current Investments (2013 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 13 years of Cash & Current Investments data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Cash & Current Investments rose 1.8% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 1.8% YoY) and the FY2026 annual result came in at $2.2 million, up 1.8% from the prior year.
- Cash & Current Investments climbed to $2.2 million in Q1 2026, from $473330.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.2 million in Q1 2026 to a low of $1205.0 in Q3 2022.
- A 5-year average of $755249.5 and a median of $473330.0 in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 95.22% — and 2023, when it jumped 15472.61%.
- Tracing ETST's Cash & Current Investments over 5 years: stood at $24188.0 in 2022, then jumped by 750.5% to $205718.0 in 2023, then soared by 688.95% to $1.6 million in 2024, then slumped by 70.84% to $473330.0 in 2025, then surged by 355.67% to $2.2 million in 2026.
- The last three Cash & Current Investments figures came in at $2.2 million (Q1 2026), $473330.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Earth Science Tech | 32.54 Mn | 29.72 Mn | 6.28 Mn | 2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.82 Mn |
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 473,330.00 |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 929,814.00 |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 707,073.00 |
| Dec 31, 2023 | 205,718.00 |
| Sep 30, 2023 | 187,650.00 |
| Jun 30, 2023 | 91,989.00 |
| Mar 31, 2023 | 35,756.00 |
| Dec 31, 2022 | 24,188.00 |
| Sep 30, 2022 | 1,205.00 |
| Jun 30, 2022 | 35,756.00 |
| Mar 31, 2022 | 26,942.00 |
| Dec 31, 2021 | 10,586.00 |
| Sep 30, 2021 | 25,217.00 |